AdnaGen Circulating Tumor Cell Detection

Characterize disease progression in Cancer for targeted therapies

Circulating tumor cells (CTCs) are a decisive factor for the emergence of metastases – to be identified and analysed in patient’s blood. The molecular characterization of CTCs offers a portrait of the specific disease state over time. The AdnaTest platform offers a diagnostic tool representing a "liquid biopsy".

Patient targeted combat against metastasis

Circulating tumor cells and their genetic profiles are an important prognostic factor in the course of therapy

High analytical sensitivity and specificity

AdnaTest is accurate, objective and easily interpretable

Easily to be integrated into clinical laboratory routines

Economic Cost Structure